Rockefeller Capital Management
ONC

Rockefeller Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Rockefeller Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Sell
6,206
-171
-3% -$50.4K ﹤0.01% 1446
2026
Q1 		$1.89M Buy
6,377
+123
+2% +$39.8K ﹤0.01% 1326
2025
Q4 		$1.9M Buy
6,254
+116
+2% +$38K ﹤0.01% 1263
2025
Q3 		$2.09M Buy
+6,138
New +$1.86M ﹤0.01% 1146
2023
Q1 		– Sell
-881
Closed -$193K – 3959
2022
Q4 		$193K Sell
881
-4
-0.5% -$734 ﹤0.01% 1677
2022
Q3 		$119K Buy
885
+68
+8% +$11.7K ﹤0.01% 1894
2022
Q2 		$132K Sell
817
-185
-18% -$28.9K ﹤0.01% 1812
2022
Q1 		$188K Buy
1,002
+188
+23% +$40K ﹤0.01% 1719
2021
Q4 		$220K Sell
814
-2
-0.2% -$675 ﹤0.01% 1608
2021
Q3 		$296K Sell
816
-5
-0.6% -$1.64K ﹤0.01% 1443
2021
Q2 		$281K Buy
821
+6
+0.7% +$1.99K ﹤0.01% 1389
2021
Q1 		$283K Sell
815
-8
-1% -$2.65K ﹤0.01% 1223
2020
Q4 		$212K Sell
823
-3
-0.4% -$826 ﹤0.01% 1174
2020
Q3 		$236K Sell
826
-14
-2% -$3.29K ﹤0.01% 990
2020
Q2 		$158K Sell
840
-16
-2% -$2.6K ﹤0.01% 1024
2020
Q1 		$105K Sell
856
-411
-32% -$64.3K ﹤0.01% 1002
2019
Q4 		$210K Sell
1,267
-307
-20% -$51K ﹤0.01% 756
2019
Q3 		$193K Sell
1,574
-234,680
-99% -$31.2M ﹤0.01% 640
2019
Q2 		$29.3M Sell
236,254
-870
-0.4% -$110K 0.41% 58
2019
Q1 		$31.3M Buy
237,124
+8,478
+4% +$1.14M 0.45% 53
2018
Q4 		$32.1M Buy
228,646
+204,621
+852% +$27.1M 0.56% 45
2018
Q3 		$4.14M Buy
24,025
+23,148
+2,639% +$3.89M 0.06% 128
2018
Q2 		$135K Buy
+877
New +$156K ﹤0.01% 365

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rockefeller Capital Management's ONC Position: Q2 2026 in Review

Rockefeller Capital Management reduced its BeOne Medicines Ltd (ONC) stake by 2.7% in Q2 2026, selling an estimated $50.4K and leaving 6,206 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

Rockefeller Capital Management first reported a position in ONC in Q2 2018 and has held it in 23 quarters since. The position peaked at $32.1M in Q4 2018. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Rockefeller Capital Management held 6,206 shares of BeOne Medicines Ltd worth $1.77M as of Q2 2026.
  • Rockefeller Capital Management sold 171 BeOne Medicines Ltd shares in Q2 2026, an estimated $50.4K.
  • BeOne Medicines Ltd made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1446 holding.
  • Rockefeller Capital Management first reported a position in BeOne Medicines Ltd in Q2 2018 and has held it in 23 quarters since.
  • Rockefeller Capital Management's BeOne Medicines Ltd position peaked at $32.1M in Q4 2018.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.